Vir Biotechnology Inc (VIR)
9.55
+0.18
(+1.92%)
USD |
NASDAQ |
Nov 05, 11:31
Vir Biotechnology Gross Profit Margin (Quarterly): 82.70% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 82.70% |
| June 30, 2024 | 94.47% |
| March 31, 2024 | 99.88% |
| December 31, 2023 | 91.69% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 95.92% |
| Date | Value |
|---|---|
| December 31, 2022 | 72.48% |
| September 30, 2022 | 94.01% |
| June 30, 2022 | |
| March 31, 2022 | 92.67% |
| December 31, 2021 | 92.98% |
| September 30, 2021 | 92.37% |
| June 30, 2021 | 99.34% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
72.48%
Minimum
Dec 2022
99.88%
Maximum
Mar 2024
91.68%
Average
92.98%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| Biomarin Pharmaceutical Inc | 74.73% |
| Arbutus Biopharma Corp | -- |
| GlycoMimetics Inc | -- |
| FibroGen Inc | 89.78% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.62% |
| Return on Assets | -29.88% |
| Return on Invested Capital | -35.62% |
| Profit Margin (Quarterly) | -73.95K% |
| Operating Margin (Quarterly) | -75.64K% |
| Return on Net Operating Assets | -280.9% |